Videos and news


Annie Diamond (Wellness Diva) talks to Dr. Joachim Fluhrer about Circulating Tumour Cells, the cells that escape the primary tumour and have the potential to metastasize.

In this Genostics podcast, Dr. Joachim Fluhrer and Dr. Katherina Pachmann talk about Circulating Tumour Cells: what they are, their importance, and how to detect them. Dr. Joachim Fluhrer: "Circulating Tumour Cell assessment in Australia has been fairly new, it's not yet widely used.

Genostics® partners with world-class cancer research laboratories in Europe to bring the very best in personalised cancer testing to the Australian and New Zealand medical communities.

We engage with pioneering practitioners who seek to discover the exact nature of each patient's cancer. These practitioners use Genostics® tests to help design personalised treatment plans and to closely monitor the effectiveness of therapies.

Specialising in the field of Oncology, we are proud to be bringing the future of personalised cancer testing to patients, today.


Informative videos:

In this Genostics videocast, Dr. Joachim Fluhrer and Prof. Katharina Pachmann discuss the detection of Circulating Tumour Cells (CTCs), the metastisising populatin of cancer cells, in the blood stream.

On this Genostics videocast, Dr. Joachim Fluhrer and Prof. Katharina Pachmann discuss the relevance of Circulating Tumour Cells in the bloodstream.

In this Genostics videocast, Dr. Joachim Fluhrer and Prof. Katharina Pachmann discuss the science of Maintrac technology for counting and analysing Circulating Tumour Cells.

In this Genostics videocast, Dr. Joachim Fluhrer and Prof. Katharina Pachmann discuss the clinical utility of Maintrac Circulating Tumour Cell testing.

On this Genostics videocast, Dr. Joachim Fluhrer and Prof. Katharina Pachmann discuss the scientific validation of Maintrac CTC testing.

 

News!


24 Sept 2015

Dr. Fluhrer will be presenting at the World CTC Symposium in Melbourne on 10 October 2015. Genostics will be available for general enquiries in the exhibition hall


August 5 2015

Your lifestyle is an on/off switch for your genes ...Find out more


June 30, 2015

Detecting the rare, renegade cancer cells ...Learn more


June 18, 2015

Survival of the fittest in cancer ...Quick read of this blog


June 8, 2015

"Even if surgery, chemotherapy, or radiation removes all traces of known cancer, there is still a risk of the cancer returning, often in a distant location in the body. This may occur as a result of CTCs."
...Read the article


June 2, 2015

Which chemotherapy kills the cells responsible for cancer spread, doctor?
...Learn more


May 18, 2015

Gene expression and the regulation of genes
...Read this article


May 11, 2015

Genetics, explained simply
...Read this blog post


May 5, 2015

What is a biomarker, and how are CTCs defined as both a biomarkers and carriers of biomarkers? ...Learn more


April 27, 2015

Circulating Tumour Cells: tell me more ...Read this article


April 20, 2014

How cancer spreads: the biology of metastasis ...Quick view


April 13 2015

DNA, Cancer, and what it takes for a cell to become cancerous ...Read this blog post


March 2015

Blog launch

We are very excited to announce the launch of the world's first Circulating Tumour Cell blog, written specifically for practitioners and their patients.


February 2015

Cancer Deconstructed

Dr. Fluhrer gives NewYou an in-depth look at the
intertwined world of cancer testing and molecular medicine.

"In what specific ways can personalised cancer testing and molecular medicine revolutionise the way people treat and think of cancer?

Every person is a separate individual, similarly every cancer is also ‘individual’ to the person affected, in a manner of speaking; cancer is heterogeneous. Cells in a malignant tumour can include cancer stem cells, promoter cells, communication cells, supportive cells, immune cells etc. Some of the cancer cells produce proteins that inhibit the immune system to recognise them and kill it." ...Read the rest of this article


December 2014

'Best of the best' publication

Prof. Pachmann's poster, outlining the use of Maintrac® technology in uncovering the heterogenous nature of Circulating Tumour Cells, was awarded 'The best of the best' poster at the Clinical Oncology Society of Australia conference. Somatic mutations of the EGFR, KRAS and BRAF genes: homogeneitiy in single cells from cell lines and heterogeneity in Circulating Epithelial Tumor Cells (CETCs) as determined using cobas® z480 analyzer (2014) ...Quick view